Merck tops New Jersey life sciences employers list
Merck leads New Jersey's largest life sciences employers, followed by NJIT, BD and Montclair State University.
BD pledges $110M to expand Nebraska syringe manufacturing
BD plans to invest $110 million to upgrade syringe manufacturing in Nebraska, expanding capacity, adding jobs and supporting demand for biologics and GLP-1 drugs.
NJ hospitals, medtech firms drive cardiac innovation
Health care providers and companies are employing AI, wearables – and partnerships – to improve heart care and patient outcomes.
BD invests $35M to expand syringe plant in Nebraska
The move builds on the Franklin Lakes-based medical technology company's broader commitment to strengthen U.S. health care infrastructure and ensure long-term supply resilience.
BD to spin off biosciences, diagnostics businesses in $17.5B deal (updated)
Earlier this year, the Franklin Lakes-based company unveiled plans to divest the divisions to focus on its core business.
Medtech mindset: BD plans to divest diagnostic, biosciences divisions
According to the company, medical essentials and interventional lead the medical technology unit's business lines, bringing in about $6.2 billion and $5 billion, respectively.
BD finalizes $4.2B acquisition of Edwards Lifesciences critical care unit
The newly renamed BD Advanced Patient Monitoring’s devices are used in more than 10,000 hospitals worldwide to help medical teams better understand patients’ cardiovascular conditions.
Quest, BD collaborating on CDx solutions to match patients with treatments
“This strategic collaboration with BD will combine our expertise in developing and validating biomarkers and assays with BD's leadership in flow cytometry to offer a fully integrated solution on a larger scale," said William Finger, vice president and general manager, Pharma Services, for Quest Diagnostics.
BD to acquire Edwards Lifesciences’ critical care business for $4.2B
The Franklin Lakes-based buyer said it believes the deal will immediately add to its bottom line. It pegged the division’s growth between 6% and 7% per year.
FDA probe into China-made plastic syringes has no impact on BD, embecta
Franklin Lakes-headquartered BD and spinoff embecta, based in Parsippany, are assuring the public that their devices are manufactured domestically and safe.
High-tech wearables transform doctor-patient relationships (updated)
Thanks to smartwatches, an increasing number of people are seeing their health care provider from the comfort of their home.
NJ hospitals boldly go where no one has gone before
On the TV series “Star Trek,” Dr. McCoy could diagnose a host of ailments by simply waving his tricorder over a patient, while diagnostic sickbay beds monitored their vital signs. We’re not quite there yet, but Garden State health care institutions are getting closer.
















